Day: May 27, 2025

Strategic move into digital infrastructure includes long-term Bitcoin accumulation, potential AI data center expansion and future NASDAQ spin-out TORONTO, May 27, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH) (“Blockmate” or the “Company”), a Blockchain & Web3 venture builder focused on digital asset infrastructure, has launched its wholly owned subsidiary Blockmate Mining, a dedicated Bitcoin mining business with ambitions to become a major player in the North American market. The new entity will pursue a long-term “mine-and-hold” strategy, accumulating Bitcoin on its balance sheet as it scales operations. Blockmate Mining has secured a site in Wyoming, USA, adjacent to a major power substation, with the potential to support up to 200 megawatts (MW) of mining capacity. The Company...

MIAMI, May 27, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (“SKYX” or the “Company”), a highly disruptive smart home platform technology company with over 97 issued and pending patents globally and a growing portfolio of over 60 lighting and home décor websites, with a mission to make homes and buildings become smart, safe, and advanced as the new standard, today announced that it is set to be added to the Russell 2000® and the broad-market Russell 3000® Index following the 2025 annual reconstitution of the Russell indexes, according to a preliminary list of additions posted by FTSE Russell on May 23, 2025. SKYX’s inclusion will become effective after the U.S. market opens on June 27, 2025. Annual Russell index reconstitution ranks the Russell 2000® Index and the 3,000 largest U.S. public companies by total market...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE IN THIS STOCK EXCHANGE RELEASE BELOW. On 16 May 2025 an extraordinary general meeting of shareholders of UAB “Atsinaujinančios energetikos investicijos”, the closed-end investment company intended for informed investors (hereinafter, the “Company”) approved up to EUR 100,000,000 nominal value Unsecured Fixed Rate Note Programme (hereinafter, the “Notes”). The Company has drafted the base prospectus for the Notes issued under the programme to be introduced to trading on the regulated market AB Nasdaq Vilnius Bond list (hereinafter, the “Prospectus”), which was...

WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor conferences in June. Jefferies Global Healthcare Conference 2025, New YorkFireside ChatJune 4, 2025, at 7:35 am ET Oppenheimer Innovators in I&I Summit, New YorkPanelist: “Dermatology: AA, HS, PSO”June 25, 2025, at 10am ET Live webcasts and replays, when available, can be found under “News / Events” in the Investors section of the Avalo Therapeutics website at https://ir.avalotx.com. The archived webcast will be available for replay for at least 30 days. About Avalo Therapeutics Avalo Therapeutics is a clinical stage biotechnology company focused on...

MIAMI, May 27, 2025 (GLOBE NEWSWIRE) — Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), a leading specialty finance company, today announced that its board of directors approved a stock repurchase program where the Company may purchase up to $250,000 of common stock in privately negotiated transactions over a six-month period, expiring November 2, 2025. The program will depend on market conditions, stock price, regulatory requirements and limitations, corporate liquidity requirements, priorities and other factors. “The stock repurchase program reflects our confidence in the strategic direction, growth prospects and financial strength of the Company to support our strategic objectives,” says William Koppelmann, CEO, Standard Premium. “The program provides flexibility to return capital to shareholders and demonstrates the long-term...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA). The RENASYS TOUCH NPWT System demonstrated clinical efficacy,1,2,3,4 and operational fitness including portability,2 an intuitive interface,5,6,7 and the ability to provide a range of therapy modes, set points and cycle times that allow individualized patient care. The system will support military medical providers to administer therapy through prolonged casualty care, first surgical intervention, aeromedical transport and definitive care in military treatment facilities. RENASYS TOUCH NPWT is manufactured in the United States.  “Future...

Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device. Receipt of the CE Mark indicates compliance with European Union (EU) regulations, specifically health, safety, and environmental protection standards. With this approval, LockeT is now eligible to be placed in markets within the EU and additional countries such as the UK, Switzerland and Turkey. According to Market Data Forecast, The European Vascular Closure Devices Market in Europe was worth $3.1 billion in 2024...

Media Release COPENHAGEN, Denmark; May 27, 2025 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the 46th Goldman Sachs Annual Global Healthcare Conference in Miami, Florida at 8:00 AM EDT (2:00 PM CEST) on June 9, 2025. A webcast of the fireside chat will be available on Genmab’s website at https://ir.genmab.com/events-presentations. About Genmab Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For more than 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a...

LAS VEGAS, NV, May 27, 2025 (GLOBE NEWSWIRE) — Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced that its founder and CEO Chris Pavlovski will interview Donald Trump Jr., host of Triggered, a Rumble exclusive podcast and board member of Trump Media & Technology Group (NASDAQ: DJT), live on stage at the Bitcoin 2025 conference in Las Vegas. The conversation is titled “Uncancelable: Bitcoin, Rumble & Free Speech,” and will be live-streamed on Tuesday, May 27, 2025 at 4:30 p.m. PT from the Nakamoto Stage at The Venetian Las Vegas. Rumble also announced a partnership role with Bitcoin 2025, serving as a 3 Block sponsor of the conference. Rumble will have a significant live-streaming presence at the event with many creators producing their content on-site. “Bitcoin represents decentralization...